BASIVI BADDIGAM: Open Payments
NPI 1386645299 · CLINTON TWP, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,261 in 47 payments from 14 companies in 2025. Trend: 2023 $1,537 · 2024 $947 · 2025 $1,261
Food & beverage: $1,111Honoraria: $150
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $271 |
| Axsome Therapeutics, Inc. | 3 | $156 |
| H2-Pharma, LLC | 1 | $150 |
| Neurocrine BioSciences, Inc. | 8 | $148 |
| Teva Pharmaceuticals USA, Inc. | 5 | $114 |
| Alkermes, Inc. | 4 | $88 |
| Vanda Pharmaceuticals Inc. | 3 | $82 |
| Collegium Pharmaceutical, Inc. | 3 | $72 |
| Lundbeck LLC | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
Products named: COBENFY, Auvelity, INGREZZA, AUSTEDO XR, FANAPT, Jornay PM, REXULTI, ABILIFY ASIMTUFII.
Industry payments across MI — which companies pay providers there.
